Elizabeth Garofalo
Director/Board Member presso ACADIA PHARMACEUTICALS INC.
Patrimonio netto: 451 313 $ in data 31/03/2024
Profilo
Elizabeth A Garofalo currently works at ACADIA Pharmaceuticals, Inc., as Independent Director from 2020, Xenon Pharmaceuticals, Inc., as Independent Director from 2021, Alector, Inc., as Independent Director from 2021, Institute For Advanced Clinical Trials For Children, as Director, and EAG Pharma Consulting LLC, as Principal from 2016.
Dr. Garofalo also formerly worked at Exicure, Inc., as Chairman from 2022 to 2023, Pfizer Inc., as Head-Neuroscience & Worldwide Regulatory Affairs, Novartis International AG, as Global Head-Clinical Development & Senior VP, and Astellas Pharma Global Development, Inc., as VP & Head-Neuroscience Therapy Area.
Dr. Garofalo received her undergraduate degree from Purdue University and doctorate degree from The Indiana University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 24/11/2023 | 15 862 ( 0.01% ) | 293 288 $ | 31/03/2024 | |
ALECTOR, INC.
0.03% | 05/12/2023 | 26 250 ( 0.03% ) | 158 025 $ | 31/03/2024 |
| 08/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Elizabeth Garofalo
| Società | Posizione | Inizio |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Director/Board Member | 29/09/2020 |
| XENON PHARMACEUTICALS INC. | Director/Board Member | 03/06/2021 |
| ALECTOR, INC. | Director/Board Member | 28/09/2021 |
| EAG Pharma Consulting LLC | Corporate Officer/Principal | 01/01/2016 |
| Institute For Advanced Clinical Trials For Children | Director/Board Member | - |
Precedenti posizioni note di Elizabeth Garofalo
| Società | Posizione | Fine |
|---|---|---|
| EXICURE, INC. | Chairman | 24/02/2023 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Corporate Officer/Principal | - |
Formazione di Elizabeth Garofalo
| Purdue University | Undergraduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| PFIZER, INC. | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| ALECTOR, INC. | Health Technology |
| EXICURE, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Health Technology |
| Institute For Advanced Clinical Trials For Children | |
| EAG Pharma Consulting LLC |
- Borsa valori
- Insiders
- Elizabeth Garofalo
